C-RAD AB: Orders to South Korea

1/3/2013 3:00 AM EST

C-Rad AB
Company Announcement

C-RAD AB: Orders to South Korea

Press release 2013-01-03

Orders of six C-RAD Catalyst™ and Sentinel(TM)systems from South Korea

C-RAD AB with its three fully owned subsidiaries in Sweden and three
international sales companies are all active in the field of radiation therapy.
The C-RAD representative in South Korea, HDX Corporation has placed orders of
six Sentinel and Catalyst systems to be installed at two different sites. 

The Catalyst™ is a next-generation high performance tracking system based on
optical surface scanning and augmented reality through re-projection. Advanced
and highly optimized algorithms for non-rigid registration and deformable
models enable clinicians to perform a real-time assessment of patient
positioning errors before and during treatment delivery. Interfaces to major
vendors ensure a completely integrated workflow. 

The SentinelTM  is a dedicated system for 4DCT studies and motion detection.

The Catalyst systems will be fully equipped with advanced functionalities for
patient positioning, motion detection and respiratory gating. The Sentinel
system will be equipped with functionality for 4DCT to do prospective studies. 

The systems will be installed at two major sites in South Korea. The systems to
Korea Cancer Center Hospital will be installed at an existing accelerator
system from Varian. The systems to Soon Chun Hyang University Hospital, Seoul
will be installed at a new site with an accelerator from Elekta. 



Erik Hedlund, CEO, C-RAD AB:

”The long term relationship with HDX corporation in South Korea has developed
well. HDX is selling the C-RAD systems as a high end solution for respiratory
gating. In spite of a decline in number of linac projects, bookings of C-RAD
systems in 2012 to South Korea increased.”